Authors
Latest:
Cost Utility of Hub-and-Spoke Telestroke Networks From Societal PerspectiveA cost-utility analysis of a hub-and-spoke telestroke network showed that it was economically dominant over routine care.
Latest:
Cost Burden of Hepatitis C Virus Treatment in Commercially Insured PatientsRates of hepatitis C virus (HCV) treatment in a commercially insured population doubled after availability of new direct-acting antivirals. Member out-of-pocket spending was kept low while the health plan bore 99% of spending on HCV medications.
Latest:
Cost-effectiveness of Brentuximab Vedotin With Chemotherapy in Treatment of CD30-Expressing PTCLAn economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).
Latest:
Patient Ratings of Veterans Affairs and Affiliated HospitalsThe mean online patient rating for Veterans Affairs hospitals was higher (3.70 ± 1.3 out of 5) than the rating for affiliated hospitals (3.19 ± 1.3; P = .003).
Latest:
Guideline-Based Peer-to-Peer Consultation Optimizes Pegfilgrastim Use With No Adverse Clinical ConsequencesActive expert peer-to-peer consultation with prescribing oncologists can promote adherence to guidelines and lead to cost reductions without risk of neutropenic fever, with or without hospitalization, for patients with cancer.
Latest:
Population Health in Primary Care: Cost, Quality, and Experience ImpactAn evaluation of the use of predictive modeling for primary care resource allocation demonstrated reduced spending and improved quality and patient experience for publicly insured adults.
Latest:
Efficiency and Its Measurement: What Practitioners Need to KnowStakeholders in US healthcare are increasingly seeking to measure and improve efficiency. This article describes an efficiency concept and some practical measurement challenges.
Latest:
Two-Sided Risk in the Oncology Care ModelThe US healthcare system remains one of the most inefficient healthcare systems in the world. The Bloomberg Health-Care Efficiency Index ranked the United States 54th among 56 countries in 2018, tied with Azerbaijan and only ahead of Bulgaria. This occurs even though the United States spends $10,244 per capita annually on healthcare, a figure representing 17% of the gross domestic product.
Latest:
Medicaid Prior Authorization and Opioid Medication Abuse and OverdoseEnrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.
Latest:
Asthma Expenditures in the United States Comparing 2004 to 2006 and 1996 to 1998Increased expenditures in US asthma are driven by increased medication spending that are not offset by decreases in emergency department and hospital spending.
Latest:
Getting From Here to There: Health IT Needs for Population HealthAligning health information technology with population health requires organizations to think differently about data needs, exchange partners, and how to leverage both for evidence-based action.
Latest:
Second-line and Third-line Chemotherapy for Lung Cancer: Use and CostUsing health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.
